Skip to main content
AAN.com

Abstract

Objectives: To determine the frequency of primary collagen VI deficiency in congenital muscular dystrophy (CMD) in Japan and to establish the genotype-phenotype correlation.
Methods: We performed immunohistochemistry for collagen VI in muscles from 362 Japanese patients with CMD, and directly sequenced the three collagen VI genes, COL6A1, COL6A2, and COL6A3, in patients found to have collagen VI deficiency.
Results: In Japan, primary collagen VI deficiency accounts for 7.2% of congenital muscular deficiency. Among these patients, five had complete deficiency (CD) and 29 had sarcolemma-specific collagen VI deficiency (SSCD). We found two homozygous and three compound heterozygous mutations in COL6A2 and COL6A3 in all five patients with CD, and identified heterozygous missense mutations or in-frame small deletions in 21 patients with SSCD in the triple helical domain (THD) of COL6A1, COL6A2, and COL6A3. All mutations in SSCD were sporadic dominant. No genotype-phenotype correlation was seen.
Conclusion: Primary collagen VI deficiency is the second most common CMD after Fukuyama type CMD in Japan. Dominant mutations located in the N-terminal side from the cysteine residue in the THD of COL6A1, COL6A2, and COL6A3 are closely associated with SSCD.

Get full access to this article

View all available purchase options and get full access to this article.

Supplementary Material

File (e1.doc)

REFERENCES

1.
Ullrich O. Kongenitale, atonisch-sklerotische Muskeldystrophie, ein weiterer Typus der heredodegenerativen Erkrankungen des neuromuskulären Systems. Z Ges Neurol Psychiatry 1930;126:171–201.
2.
Nonaka I, Une Y, Ishihara T, Miyoshino S, Nakashima T, Sugita H. A clinical and histological study of Ullrich's disease (congenital atonic-sclerotic muscular dystrophy). Neuropediatrics 1981;12:197–208.
3.
Mercuri E, Yuva Y, Brown SC, et al. Collagen VI involvement in Ullrich syndrome: a clinical, genetic, and immunohistochemical study. Neurology 2002;58:1354–1359.
4.
Bethlem J, Wijngaarden GK. Benign myopathy, with autosomal dominant inheritance. A report on three pedigrees. Brain 1976;99:91–100.
5.
Baker NL, Morgelin M, Peat R, et al. Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy. Hum Mol Genet 2005;14:279–293.
6.
Lampe AK, Dunn DM, von Niederhausern AC, et al. Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Bethlem myopathy. J Med Genet 2005;42:108–120.
7.
Giusti B, Lucarini L, Pietroni V, et al. Dominant and recessive COL6A1 mutations in Ullrich scleroatonic muscular dystrophy. Ann Neurol 2005;58:400–410.
8.
Ishikawa H, Sugie K, Murayama K, et al. Ullrich disease: collagen VI deficiency: EM suggests a new basis for muscular weakness. Neurology 2002;59:920–923.
9.
Ishikawa H, Sugie K, Murayama K, et al. Ullrich disease due to deficiency of collagen VI in the sarcolemma. Neurology 2004;62:620–623.
10.
Demir E, Ferreiro A, Sabatelli P, et al. Collagen VI status and clinical severity in Ullrich congenital muscular dystrophy: phenotype analysis of 11 families linked to the COL6 loci. Neuropediatrics 2004;35:103–112.
11.
Pan TC, Zhang RZ, Sudano DG, Marie SK, Bonnemann CG, Chu ML. New molecular mechanism for Ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype. Am J Hum Genet 2003;73:355–369.
12.
Demir E, Sabatelli P, Allamand V, et al. Mutations in COL6A3 cause severe and mild phenotypes of Ullrich congenital muscular dystrophy. Am J Hum Genet 2002;70:1446–1458.
13.
Camacho Vanegas O, Bertini E, et al. Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI. Proc Natl Acad Sci USA 2001;98:7516–7521.
14.
Lampe AK, Bushby KM. Collagen VI related muscle disorders. J Med Genet 2005;42:673–685.
15.
Voit T. Congenital muscular dystrophies: 1997 update. Brain Dev 1998;20:65–74.
16.
Sambrook J, Russell DW. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 2001.
17.
Lucioli S, Giusti B, Mercuri E, et al. Detection of common and private mutations in the COL6A1 gene of patients with Bethlem myopathy. Neurology 2005;64:1931–1937.
18.
Silan F, Yoshioka M, Kobayashi K, et al. A new mutation of the fukutin gene in a non-Japanese patient. Ann Neurol 2003;53:392–396.
19.
Dubowitz V. 41st ENMC International Workshop on Congenital Muscular Dystrophy 8-10 March 1996, Naarden, The Netherlands. Neuromuscul Disord 1996;6:295–306.
20.
Dubowitz V, Fardeau M. Proceedings of the 27th ENMC sponsored workshop on congenital muscular dystrophy. 22–24 April 1994, The Netherlands. Neuromuscul Disord 1995;5:253–258.
21.
Chu ML, Conway D, Pan TC, et al. Amino acid sequence of the triple-helical domain of human collagen type VI. J Biol Chem 1988;263:18601–18606.
22.
Chu ML, Pan TC, Conway D, et al. Sequence analysis of alpha 1(VI) and alpha 2(VI) chains of human type VI collagen reveals internal triplication of globular domains similar to the A domains of von Willebrand factor and two alpha 2(VI) chain variants that differ in the carboxy terminus. EMBO J 1989;8:1939–1946.
23.
Chu ML, Zhang RZ, Pan TC, et al. Mosaic structure of globular domains in the human type VI collagen alpha 3 chain: similarity to von Willebrand factor, fibronectin, actin, salivary proteins and aprotinin type protease inhibitors. EMBO J 1990;9:385–393.
24.
Ball S, Bella J, Kielty C, Shuttleworth A. Structural basis of type VI collagen dimer formation. J Biol Chem 2003;278:15326–15332.
25.
Kuo HJ, Maslen CL, Keene DR, et al. Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen. J Biol Chem 1997;272:26522–26529.
26.
Kawahara G, Okada M, Morone N, et al. Reduced cell anchorage may cause sarcolemma-specific collagen VI deficiency in Ullrich disease. Neurology 2007;69:1043–1049.
27.
Lucarini L, Giusti B, Zhang RZ, et al. A homozygous COL6A2 intron mutation causes in-frame triple-helical deletion and nonsense-mediated mRNA decay in a patient with Ullrich congenital muscular dystrophy. Hum Genet 2005;117:460–466.
28.
Jimenez-Mallebrera C, Maioli MA, Kim J, et al. A comparative analysis of collagen VI production in muscle, skin and fibroblasts from 14 Ullrich congenital muscular dystrophy patients with dominant and recessive COL6A mutations. Neuromuscul Disord 2006;16:571–582.
29.
Lamandé SR, Mörgelin M, Selan C, et al. Kinked collagen VI tetramers and reduced microfibril formation as a result of Bethlem myopathy and introduced triple helical glycine mutations. J Biol Chem 2002;277:1949–1956.
30.
Tetreault M, Duquette A, Thiffault I, et al. A new form of congenital muscular dystrophy with joint hyperlaxity maps to 3p23-21. Brain 2006;129:2077–2084.

Information & Authors

Information

Published In

Neurology®
Volume 69Number 10September 4, 2007
Pages: 1035-1042
PubMed: 17785673

Publication History

Published online: September 4, 2007
Published in print: September 4, 2007

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

M. Okada, MD
From the Department of Neuromuscular Research, National Institute of Neuroscience (M.O., G.K., S.N., K.S., K.M., I. Nonaka, Y.K.H., I. Nishino), National Center of Neurology and Psychiatry (NCNP), Kodaira, Tokyo; and Department of Pediatrics (M.O.), Toho University Ohashi Medical Center, Tokyo, Japan.
G. Kawahara, PhD
From the Department of Neuromuscular Research, National Institute of Neuroscience (M.O., G.K., S.N., K.S., K.M., I. Nonaka, Y.K.H., I. Nishino), National Center of Neurology and Psychiatry (NCNP), Kodaira, Tokyo; and Department of Pediatrics (M.O.), Toho University Ohashi Medical Center, Tokyo, Japan.
S. Noguchi, PhD
From the Department of Neuromuscular Research, National Institute of Neuroscience (M.O., G.K., S.N., K.S., K.M., I. Nonaka, Y.K.H., I. Nishino), National Center of Neurology and Psychiatry (NCNP), Kodaira, Tokyo; and Department of Pediatrics (M.O.), Toho University Ohashi Medical Center, Tokyo, Japan.
K. Sugie, MD, PhD
From the Department of Neuromuscular Research, National Institute of Neuroscience (M.O., G.K., S.N., K.S., K.M., I. Nonaka, Y.K.H., I. Nishino), National Center of Neurology and Psychiatry (NCNP), Kodaira, Tokyo; and Department of Pediatrics (M.O.), Toho University Ohashi Medical Center, Tokyo, Japan.
K. Murayama, BS
From the Department of Neuromuscular Research, National Institute of Neuroscience (M.O., G.K., S.N., K.S., K.M., I. Nonaka, Y.K.H., I. Nishino), National Center of Neurology and Psychiatry (NCNP), Kodaira, Tokyo; and Department of Pediatrics (M.O.), Toho University Ohashi Medical Center, Tokyo, Japan.
I. Nonaka, MD, PhD
From the Department of Neuromuscular Research, National Institute of Neuroscience (M.O., G.K., S.N., K.S., K.M., I. Nonaka, Y.K.H., I. Nishino), National Center of Neurology and Psychiatry (NCNP), Kodaira, Tokyo; and Department of Pediatrics (M.O.), Toho University Ohashi Medical Center, Tokyo, Japan.
Y. K. Hayashi, MD, PhD
From the Department of Neuromuscular Research, National Institute of Neuroscience (M.O., G.K., S.N., K.S., K.M., I. Nonaka, Y.K.H., I. Nishino), National Center of Neurology and Psychiatry (NCNP), Kodaira, Tokyo; and Department of Pediatrics (M.O.), Toho University Ohashi Medical Center, Tokyo, Japan.
I. Nishino, MD, PhD
From the Department of Neuromuscular Research, National Institute of Neuroscience (M.O., G.K., S.N., K.S., K.M., I. Nonaka, Y.K.H., I. Nishino), National Center of Neurology and Psychiatry (NCNP), Kodaira, Tokyo; and Department of Pediatrics (M.O.), Toho University Ohashi Medical Center, Tokyo, Japan.

Notes

Address correspondence and reprint requests to Dr. Ichizo Nishino, Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), 4-1-1 Ogawahigashi-cho, Kodaira, Tokyo, 187-8502 Japan [email protected]

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Muscular Dystrophies, International Encyclopedia of Public Health, (107-126), (2025).https://doi.org/10.1016/B978-0-323-99967-0.00185-X
    Crossref
  2. Phase 1 Open-Label Study of Omigapil in Patients With LAMA2- or COL6-Related Dystrophy, Neurology Genetics, 10, 3, (2024)./doi/10.1212/NXG.0000000000200148
    Abstract
  3. Splicing Switching of Alternative Last Exons Due to a Deletion Including Canonical Polyadenylation Site in COL6A2 Gene Causes Recessive UCMD, Neurology Genetics, 10, 2, (2024)./doi/10.1212/NXG.0000000000200137
    Abstract
  4. A novel homozygous nonsense variant in COL12A1 causes myopathic Ehlers‐Danlos syndrome: A case report and literature review , Neuropathology and Applied Neurobiology, 50, 4, (2024).https://doi.org/10.1111/nan.13004
    Crossref
  5. Collagen diseases, Biochemistry of Collagens, Laminins and Elastin, (371-398), (2024).https://doi.org/10.1016/B978-0-443-15617-5.00046-9
    Crossref
  6. Congenital Muscular Dystrophies, Principles and Practice of the Muscular Dystrophies, (175-191), (2024).https://doi.org/10.1007/978-3-031-44009-0_11
    Crossref
  7. Features of Congenital Arthrogryposis Due to Abnormalities in Collagen Homeostasis, a Scoping Review, International Journal of Molecular Sciences, 24, 17, (13545), (2023).https://doi.org/10.3390/ijms241713545
    Crossref
  8. Collagen VI-related myopathies: clinical variability, phenotype-genotype correlation and exploratory transcriptome study, Neuromuscular Disorders, 33, 5, (371-381), (2023).https://doi.org/10.1016/j.nmd.2023.03.003
    Crossref
  9. A 7‐year‐old female with hypotonia and scoliosis, Brain Pathology, 32, 6, (2022).https://doi.org/10.1111/bpa.13076
    Crossref
  10. Congenital muscle dystrophies: Role of singleton whole exome sequencing in countries with limited resources, Clinical Neurology and Neurosurgery, 217, (107271), (2022).https://doi.org/10.1016/j.clineuro.2022.107271
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share